Your browser doesn't support javascript.
loading
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.
Orcutt-Jahns, Brian; Junior, Joao Rodrigues Lima; Rockne, Russell C; Matache, Adina; Branciamore, Sergio; Hung, Ethan; Rodin, Andrei S; Lee, Peter P; Meyer, Aaron S.
Afiliação
  • Orcutt-Jahns B; Department of Bioengineering, University of California, Los Angeles (UCLA), USA.
  • Junior JRL; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Rockne RC; Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Matache A; Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Branciamore S; Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Hung E; Department of Bioengineering, University of California, Los Angeles (UCLA), USA.
  • Rodin AS; Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Lee PP; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
  • Meyer AS; Department of Bioengineering, University of California, Los Angeles (UCLA), USA.
bioRxiv ; 2023 Nov 03.
Article em En | MEDLINE | ID: mdl-37961682
ABSTRACT
Cytokines mediate cell-to-cell communication across the immune system and therefore are critical to immunosurveillance in cancer and other diseases. Several cytokines show dysregulated abundance or signaling responses in breast cancer, associated with the disease and differences in survival and progression. Cytokines operate in a coordinated manner to affect immune surveillance and regulate one another, necessitating a systems approach for a complete picture of this dysregulation. Here, we profiled cytokine signaling responses of peripheral immune cells from breast cancer patients as compared to healthy controls in a multidimensional manner across ligands, cell populations, and responsive pathways. We find alterations in cytokine responsiveness across pathways and cell types that are best defined by integrated signatures across dimensions. Alterations in the abundance of a cytokine's cognate receptor do not explain differences in responsiveness. Rather, alterations in baseline signaling and receptor abundance suggesting immune cell reprogramming are associated with altered responses. These integrated features suggest a global reprogramming of immune cell communication in breast cancer.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article